Aditxt, Inc. Debt Conversion, Converted Instrument, Warrants or Options Issued
Aditxt, Inc. (ADTX) reported Debt Conversion, Converted Instrument, Warrants or Options Issued of 91.67 thousand shares for the 1-month period ending 2021-08-31, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 · last filed 2023-08-14
- 2021-08-31: Debt Conversion, Converted Instrument, Warrants or Options Issued 1 month 91.67K shares; Debt Conversion, Converted Instrument, Warrants or Options Issued 1 month as first filed 4.58M shares.
| Period end | Debt Conversion, Converted Instrument, Warrants or Options Issued 1 month | Debt Conversion, Converted Instrument, Warrants or Options Issued 1 month as first filed |
|---|---|---|
| 2021-08-31 | 91.67K shares 10-Q · filed 2023-08-14 | 4.58M shares 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |